Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2313402,Anxrr24,Anxiety related response QTL 24,,,aggression-related behavior trait (VT:0015014),tameness/aggressiveness composite score (CMO:0002136),1,49147799,156446783,Rat,n/a,region,qtl 1000,1554320,Bmd1,Bone mineral density QTL 1,12.2,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),1,254393,86904217,Rat,n/a,region,qtl 1000,2300164,Bmd44,Bone mineral density QTL 44,5.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),1,58209327,103209327,Rat,n/a,region,qtl 1000,2313098,Bmd70,Bone mineral density QTL 70,3.6,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313092,Bmd72,Bone mineral density QTL 72,2.5,0.0001,tibia mineral mass (VT:1000283),total volumetric bone mineral density (CMO:0001728),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313062,Bmd73,Bone mineral density QTL 73,3.9,0.0001,tibia mineral mass (VT:1000283),cortical volumetric bone mineral density (CMO:0001730),1,11314489,83657083,Rat,n/a,region,qtl 1000,1578649,Bmd8,Bone mineral density QTL 8,4.9,,femur mineral mass (VT:0010011),trabecular volumetric bone mineral density (CMO:0001729),1,49578577,94578577,Rat,n/a,region,qtl 1000,1300172,Bp172,Blood pressure QTL 172,3.56,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),1,35377508,94364229,Rat,n/a,region,qtl 1000,1549903,Bp267,Blood pressure QTL 267,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,79134941,113593716,Rat,n/a,region,qtl 1000,7421628,Bp361,Blood pressure QTL 361,,0.001,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),1,64588516,125875986,Rat,n/a,region,qtl 1000,10059597,Bp377,Blood pressure QTL 377,3.42,0.025,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,35377692,217372257,Rat,n/a,region,qtl 1000,70225,Bp58,Blood pressure QTL 58,3.3,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,34993530,173445086,Rat,n/a,region,qtl 1000,631495,Bp96,Blood pressure QTL 96,4.52,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),1,23406428,108057505,Rat,n/a,region,qtl 1000,1578654,Bss10,Bone structure and strength QTL 10,4,,femur morphology trait (VT:0000559),femoral neck cortical cross-sectional area (CMO:0001702),1,49578577,169852184,Rat,n/a,region,qtl 1000,2313072,Bss53,Bone structure and strength QTL 53,4.3,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313078,Bss54,Bone structure and strength QTL 54,3.5,0.0001,tibia area (VT:1000281),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313059,Bss55,Bone structure and strength QTL 55,3.2,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313099,Bss56,Bone structure and strength QTL 56,2.4,0.0001,tibia size trait (VT:0100001),tibia midshaft endosteal cross-sectional area (CMO:0001716),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313051,Bss57,Bone structure and strength QTL 57,3.7,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313094,Bss58,Bone structure and strength QTL 58,3.7,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,43579208,126240667,Rat,n/a,region,qtl 1000,2313075,Bss66,Bone structure and strength QTL 66,3.4,0.0001,tibia length (VT:0004357),tibia length (CMO:0000450),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313065,Bss67,Bone structure and strength QTL 67,3.1,0.0001,tibia area (VT:1000281),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313069,Bss68,Bone structure and strength QTL 68,2.9,0.0001,tibia size trait (VT:0100001),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313077,Bss69,Bone structure and strength QTL 69,3.5,0.0001,tibia strength trait (VT:1000284),bone polar moment of inertia (CMO:0001558),1,11314489,83657083,Rat,n/a,region,qtl 1000,2313097,Bss70,Bone structure and strength QTL 70,3.5,0.0001,tibia strength trait (VT:1000284),tibia total energy absorbed before break (CMO:0001736),1,11314489,83657083,Rat,n/a,region,qtl 1000,4889919,Bss86,Bone structure and strength QTL 86,4.1,,tibia area (VT:1000281),tibia midshaft total cross-sectional area (CMO:0001715),1,53851348,83657083,Rat,n/a,region,qtl 1000,4889929,Bss87,Bone structure and strength QTL 87,6.7,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,53851348,83657083,Rat,n/a,region,qtl 1000,4889962,Bss94,Bone structure and strength QTL 94,3.8,,tibia area (VT:1000281),tibia-fibula cortical bone endosteal cross-sectional area (CMO:0001722),1,49547328,83657083,Rat,n/a,region,qtl 1000,61433,Cia2,Collagen induced arthritis QTL 2,5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),1,79689765,94909507,Rat,n/a,region,qtl 1000,4889451,Eae29,Experimental allergic encephalomyelitis QTL 29,5.51,,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),1,5655772,85706974,Rat,n/a,region,qtl 1000,631688,Hcas2,Hepatocarcinoma susceptibility QTL 2,3,0.0001,liver integrity trait (VT:0010547),liver tumorous lesion number (CMO:0001068),1,5655769,122614963,Rat,n/a,region,qtl 1000,1300121,Hrtrt1,Heart rate QTL 1,3.7,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),1,66113339,122614963,Rat,n/a,region,qtl 1000,9589820,Insglur3,Insulin/glucose ratio QTL 3,10.75,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),1,35854167,80854167,Rat,n/a,region,qtl 1000,2298545,Neuinf8,Neuroinflammation QTL 8,4.6,,nervous system integrity trait (VT:0010566),spinal cord beta-2 microglobulin mRNA level (CMO:0002125),1,58354072,161711996,Rat,n/a,region,qtl 1000,634314,Niddm44,Non-insulin dependent diabetes mellitus QTL 44,,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),1,49578693,217054291,Rat,n/a,region,qtl 1000,2302059,Pia36,Pristane induced arthritis QTL 36,3.8,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),1,41907249,86907249,Rat,n/a,region,qtl 1000,8552900,Pigfal1,Plasma insulin-like growth factor 1 level QTL 1,7.4,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,8552948,Pigfal11,Plasma insulin-like growth factor 1 level QTL 11,4.7,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),1,35854167,80854167,Rat,n/a,region,qtl 1000,6903308,Scl36,Serum cholesterol QTL 36,2,0.0125,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),1,50522714,94225616,Rat,n/a,region,qtl 1000,631512,Scl6,Serum cholesterol level QTL 6,9.6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),1,67227683,94201552,Rat,n/a,region,qtl 1000,1358359,Sradr1,Stress Responsive Adrenal Weight QTL 1,4.74,,adrenal gland mass (VT:0010420),both adrenal glands wet weight (CMO:0000164),1,25951907,130917265,Rat,n/a,region,qtl 1000,7411712,Strs4,Sensitivity to stroke QTL 4,8.7,,cerebrum integrity trait (VT:0010549),percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932),1,79689548,124689548,Rat,n/a,region,qtl